Home›People›Zia Huque
ZH

Zia Huque

Director at Gilgamesh Pharma. Also a director at Halo Industries, Paradromics and Prime Movers Lab.

InvestorDirectorRoles at 3 startupsPrime Movers Lab
Updated Nov 9, 2026·Latest SEC filing Mar 31, 2026·Suggest an edit

About Zia Huque

Zia Huque is a director at Gilgamesh Pharma.

Form D filings also name Zia Huque as a director at Halo Industries and Paradromics.

Zia Huque appears on fund filings for Prime Movers Lab.

Zia Huque first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Zia Huque in the role, so the role may have started earlier or lasted longer.

Gilgamesh Pharma Inc.
Director
2026 · New York, NY
Develops medicines for people with psychiatric and neurological disorders.
Halo Industries, Inc.
Director
2024 · Santa Clara, CA
Paradromics, Inc.
Director
2023 · Austin, TX
Prime Movers Lab
Director
2022 · Fund filings for 1 fund

Key Colleagues at Startups

The people Zia Huque works with at each company, as listed on that company's latest Form D.

Gilgamesh Pharma Inc. · Form D, Mar 31, 2026
AK
Amy Kruse
Director
Jonathan Sporn
Jonathan Sporn
Founder, CEO and director
PS
RB
Andrew Kruegel
Andrew Kruegel
Co-Founder, CSO and director
Halo Industries, Inc. · Form D, May 8, 2024
DS
Dakin Sloss
Resignation As A Director On 4/24/2024
DA
Dan Armbrust
Director
PS
Philip Van Stockum
Resignation As A Director On 4/26/2024
KH
AI
Andrei Iancu
President and director
ES
Paradromics, Inc. · Form D/A, Nov 7, 2023
HE
Helmy Eltoukhy
Executive officer and director
MA
Matthew Angle
CEO and director
AK
Amy Kruse
Director

Sources

  1. SECGilgamesh Pharma Inc. Form D, filed Mar 31, 2026
  2. SECHalo Industries, Inc. Form D, filed May 8, 2024
  3. SECParadromics, Inc. Form D/A, filed Nov 7, 2023